Skip to main content
Erschienen in: Clinical Rheumatology 4/2015

01.04.2015 | Original Article

The value of FDG-PET in the diagnosis of thromboangiitis obliterans—a case series

verfasst von: Gerald Hackl, Robert Milosavljevic, Klara Belaj, Thomas Gary, Peter Rief, Franz Hafner, Rainer W. Lipp, Marianne Brodmann

Erschienen in: Clinical Rheumatology | Ausgabe 4/2015

Einloggen, um Zugang zu erhalten

Abstract

Thromboangiitis obliterans (TAO) is an inflammatory vascular disease affecting dominantly the vessels of the extremities and is etiologically strongly associated with tobacco consumption. Different imaging techniques are generally used to exclude potential differential diagnoses. We investigated the value of 18 F-flourodeoxyglucose positron emission tomography ([18 F]FDG-PET) in the diagnosis of TAO. All consecutive patients with diagnosed TAO between Nov 2001 and Nov 2003 at our institution who underwent [18 F]FDG-PET in the diagnostic workup were analyzed retrospectively. Whole-body scans were conducted after a fasting period of at least 6 h and blood glucose levels lower than 180 mg/dl. The primary endpoint was defined as significantly increased vascular FDG uptake. Tracer uptake was visually determined and, in accordance with strength, divided into grades 0 to 3. In total, ten patients were statistically evaluated. The median patient age at the date of the first [18 F]FDG-PET was 41.5 years. Repetitive FDG-PET imaging was performed in seven out of ten patients (70 %). The endpoint was objectified in one of the initial examinations (10 %) and in another one out of seven follow-up scans (14.3 %). One positive [18 F]FDG-PET was observed in the pelvic vessels and the other in the infrapopliteal arteries. Therefore, increased tracer uptake could be observed in two examinations on two different patients (both with grade 3 tracer uptake) out of 17 conducted [18 F]FDG-PETs in total. The [18 F]FDG-PET was not a suitable investigative procedure for the diagnosis of TAO in the present patient cohort.
Literatur
1.
Zurück zum Zitat Zerizer I, Tan K, Khan S, Barwick T, Marzola MC, Rubello D, Al-Nahhas A (2010) Role of FDG-PET and PET/CT in the diagnosis and management of vasculitis. Eur J Radiol 73:504–509CrossRefPubMed Zerizer I, Tan K, Khan S, Barwick T, Marzola MC, Rubello D, Al-Nahhas A (2010) Role of FDG-PET and PET/CT in the diagnosis and management of vasculitis. Eur J Radiol 73:504–509CrossRefPubMed
2.
4.
Zurück zum Zitat Cachovan M (1988) Epidemiologie und geographisches Verteilungsmuster der Thromboangiitis obliterans. In: Heidrich J (ed) Thromboangiitis obliterans morbus Winiwarter-Buerger, George Thieme. Stuttgart, New York, pp 31–36 Cachovan M (1988) Epidemiologie und geographisches Verteilungsmuster der Thromboangiitis obliterans. In: Heidrich J (ed) Thromboangiitis obliterans morbus Winiwarter-Buerger, George Thieme. Stuttgart, New York, pp 31–36
5.
Zurück zum Zitat Shionoya S (1998) Diagnostic criteria of Buerger’s disease. Int J Cardiol 66(Suppl 1):S243–S245, discussion S247CrossRefPubMed Shionoya S (1998) Diagnostic criteria of Buerger’s disease. Int J Cardiol 66(Suppl 1):S243–S245, discussion S247CrossRefPubMed
6.
Zurück zum Zitat Brodmann M, Lipp RW, Passath A, Seinost G, Pabst E, Pilger E (2004) The role of 2-18 F-fluoro-2-deoxy-D-glucose positron emission tomography in the diagnosis of giant cell arteritis of the temporal arteries. Rheumatology (Oxford) 43:241–242CrossRef Brodmann M, Lipp RW, Passath A, Seinost G, Pabst E, Pilger E (2004) The role of 2-18 F-fluoro-2-deoxy-D-glucose positron emission tomography in the diagnosis of giant cell arteritis of the temporal arteries. Rheumatology (Oxford) 43:241–242CrossRef
7.
Zurück zum Zitat Blockmans D, Stroobants S, Maes A, Mortelmans L (2000) Positron emission tomography in giant cell arteritis and polymyalgia rheumatica: evidence for inflammation of the aortic arch. Am J Med 108:246–249CrossRefPubMed Blockmans D, Stroobants S, Maes A, Mortelmans L (2000) Positron emission tomography in giant cell arteritis and polymyalgia rheumatica: evidence for inflammation of the aortic arch. Am J Med 108:246–249CrossRefPubMed
8.
Zurück zum Zitat Beggs AD, Hain SF (2002) F-18 FDG-positron emission tomographic scanning and Wegener’s granulomatosis. Clin Nucl Med 27:705–706CrossRefPubMed Beggs AD, Hain SF (2002) F-18 FDG-positron emission tomographic scanning and Wegener’s granulomatosis. Clin Nucl Med 27:705–706CrossRefPubMed
9.
Zurück zum Zitat Ueda N, Inoue Y, Himeji D, Shimao Y, Oryoji K, Mitoma H, Arinobu Y, Niiro H, Tsukamoto H, Horiuchi T, Ueda A, Akashi K (2010) Wegener’s granulomatosis detected initially by integrated 18 F-fluorodeoxyglucose positron emission tomography/computed tomography. Mod Rheumatol 20:205–209CrossRefPubMed Ueda N, Inoue Y, Himeji D, Shimao Y, Oryoji K, Mitoma H, Arinobu Y, Niiro H, Tsukamoto H, Horiuchi T, Ueda A, Akashi K (2010) Wegener’s granulomatosis detected initially by integrated 18 F-fluorodeoxyglucose positron emission tomography/computed tomography. Mod Rheumatol 20:205–209CrossRefPubMed
10.
Zurück zum Zitat Bleeker-Rovers CP, Bredie SJ, van der Meer JW, Corstens FH, Oyen WJ (2003) F-18-fluorodeoxyglucose positron emission tomography in diagnosis and follow-up of patients with different types of vasculitis. Neth J Med 61:323–329PubMed Bleeker-Rovers CP, Bredie SJ, van der Meer JW, Corstens FH, Oyen WJ (2003) F-18-fluorodeoxyglucose positron emission tomography in diagnosis and follow-up of patients with different types of vasculitis. Neth J Med 61:323–329PubMed
11.
Zurück zum Zitat Weinberg I, Jaff MR (2012) Nonatherosclerotic arterial disorders of the lower extremities. Circulation 126:213–222CrossRefPubMed Weinberg I, Jaff MR (2012) Nonatherosclerotic arterial disorders of the lower extremities. Circulation 126:213–222CrossRefPubMed
12.
Zurück zum Zitat Suzuki S, Yamada I, Himeno Y (1996) Angiographic findings in Buerger disease. Int J Cardiol 54(Suppl):S189–S195CrossRefPubMed Suzuki S, Yamada I, Himeno Y (1996) Angiographic findings in Buerger disease. Int J Cardiol 54(Suppl):S189–S195CrossRefPubMed
13.
Zurück zum Zitat Fujii Y, Soga J, Nakamura S, Hidaka T, Hata T, Idei N, Fujimura N, Nishioka K, Chayama K, Kihara Y, Higashi Y (2010) Classification of corkscrew collaterals in thromboangiitis obliterans (Buerger’s disease): relationship between corkscrew type and prevalence of ischemic ulcers. Circ J 74:1684–1688CrossRefPubMed Fujii Y, Soga J, Nakamura S, Hidaka T, Hata T, Idei N, Fujimura N, Nishioka K, Chayama K, Kihara Y, Higashi Y (2010) Classification of corkscrew collaterals in thromboangiitis obliterans (Buerger’s disease): relationship between corkscrew type and prevalence of ischemic ulcers. Circ J 74:1684–1688CrossRefPubMed
14.
Zurück zum Zitat Fujii Y, Soga J, Hidaka T, Hata T, Idei N, Fujimura N, Mikami S, Maruhashi T, Kihara Y, Noma K, Higashi Y (2011) Color doppler flows of corkscrew collaterals in Thromboangiitis obliterans (Buerger’s disease) using color duplex ultrasonography. J Am Coll Cardiol 57:2539CrossRefPubMed Fujii Y, Soga J, Hidaka T, Hata T, Idei N, Fujimura N, Mikami S, Maruhashi T, Kihara Y, Noma K, Higashi Y (2011) Color doppler flows of corkscrew collaterals in Thromboangiitis obliterans (Buerger’s disease) using color duplex ultrasonography. J Am Coll Cardiol 57:2539CrossRefPubMed
15.
Zurück zum Zitat Fujii Y, Nishioka K, Yoshizumi M, Chayama K, Higashi Y (2007) Images in cardiovascular medicine Corkscrew collaterals in thromboangitis obliterans (Buerger’s disease). Circulation 116:e539–e540CrossRefPubMed Fujii Y, Nishioka K, Yoshizumi M, Chayama K, Higashi Y (2007) Images in cardiovascular medicine Corkscrew collaterals in thromboangitis obliterans (Buerger’s disease). Circulation 116:e539–e540CrossRefPubMed
16.
Zurück zum Zitat Bauer T, Rauber K, Rau WS (1990) Differential diagnosis of acral blood circulation disorders using intra-arterial DSA of the hand. Rofo 152:271–276CrossRefPubMed Bauer T, Rauber K, Rau WS (1990) Differential diagnosis of acral blood circulation disorders using intra-arterial DSA of the hand. Rofo 152:271–276CrossRefPubMed
17.
Zurück zum Zitat Hasegawa M, Nagai Y, Tamura A, Ishikawa O (2006) Arteriographic evaluation of vascular changes of the extremities in patients with systemic sclerosis. Br J Dermatol 155:1159–1164CrossRefPubMed Hasegawa M, Nagai Y, Tamura A, Ishikawa O (2006) Arteriographic evaluation of vascular changes of the extremities in patients with systemic sclerosis. Br J Dermatol 155:1159–1164CrossRefPubMed
18.
19.
Zurück zum Zitat Muci-Mendoza R, Ramella M, Fuenmayor-Rivera D (2002) Corkscrew retinal vessels in neurofibromatosis type 1: report of 12 cases. Br J Ophthalmol 86:282–284CrossRefPubMedCentralPubMed Muci-Mendoza R, Ramella M, Fuenmayor-Rivera D (2002) Corkscrew retinal vessels in neurofibromatosis type 1: report of 12 cases. Br J Ophthalmol 86:282–284CrossRefPubMedCentralPubMed
20.
Zurück zum Zitat Larsen BT, Edwards WD, Jensen MH, Johnson CH, McBane RD, Harmsen WS, Maleszewski JJ (2013) Surgical pathology of hypothenar hammer syndrome with new pathogenetic insights: a 25-year institutional experience with clinical and pathologic review of 67 cases. Am J Surg Pathol 37:1700–1708CrossRefPubMed Larsen BT, Edwards WD, Jensen MH, Johnson CH, McBane RD, Harmsen WS, Maleszewski JJ (2013) Surgical pathology of hypothenar hammer syndrome with new pathogenetic insights: a 25-year institutional experience with clinical and pathologic review of 67 cases. Am J Surg Pathol 37:1700–1708CrossRefPubMed
21.
Zurück zum Zitat Belhocine T, Blockmans D, Hustinx R, Vandevivere J, Mortelmans L (2003) Imaging of large vessel vasculitis with (18)FDG PET: illusion or reality? A critical review of the literature data. Eur J Nucl Med Mol Imaging 30:1305–1313CrossRefPubMed Belhocine T, Blockmans D, Hustinx R, Vandevivere J, Mortelmans L (2003) Imaging of large vessel vasculitis with (18)FDG PET: illusion or reality? A critical review of the literature data. Eur J Nucl Med Mol Imaging 30:1305–1313CrossRefPubMed
22.
Zurück zum Zitat Bural GG, Torigian DA, Chamroonrat W, Houseni M, Chen W, Basu S, Kumar R, Alavi A (2008) FDG-PET is an effective imaging modality to detect and quantify age-related atherosclerosis in large arteries. Eur J Nucl Med Mol Imaging 35:562–569CrossRefPubMed Bural GG, Torigian DA, Chamroonrat W, Houseni M, Chen W, Basu S, Kumar R, Alavi A (2008) FDG-PET is an effective imaging modality to detect and quantify age-related atherosclerosis in large arteries. Eur J Nucl Med Mol Imaging 35:562–569CrossRefPubMed
23.
Zurück zum Zitat Shionoya S, Ban I, Nakata Y, Matsubara J, Hirai M, Kawai S (1978) Involvement of the iliac artery in Buerger’s disease (pathogenesis and arterial reconstruction). J Cardiovasc Surg (Torino) 19:69–76 Shionoya S, Ban I, Nakata Y, Matsubara J, Hirai M, Kawai S (1978) Involvement of the iliac artery in Buerger’s disease (pathogenesis and arterial reconstruction). J Cardiovasc Surg (Torino) 19:69–76
24.
Metadaten
Titel
The value of FDG-PET in the diagnosis of thromboangiitis obliterans—a case series
verfasst von
Gerald Hackl
Robert Milosavljevic
Klara Belaj
Thomas Gary
Peter Rief
Franz Hafner
Rainer W. Lipp
Marianne Brodmann
Publikationsdatum
01.04.2015
Verlag
Springer London
Erschienen in
Clinical Rheumatology / Ausgabe 4/2015
Print ISSN: 0770-3198
Elektronische ISSN: 1434-9949
DOI
https://doi.org/10.1007/s10067-014-2648-5

Weitere Artikel der Ausgabe 4/2015

Clinical Rheumatology 4/2015 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Erhebliches Risiko für Kehlkopfkrebs bei mäßiger Dysplasie

29.05.2024 Larynxkarzinom Nachrichten

Fast ein Viertel der Personen mit mäßig dysplastischen Stimmlippenläsionen entwickelt einen Kehlkopftumor. Solche Personen benötigen daher eine besonders enge ärztliche Überwachung.

Nach Herzinfarkt mit Typ-1-Diabetes schlechtere Karten als mit Typ 2?

29.05.2024 Herzinfarkt Nachrichten

Bei Menschen mit Typ-2-Diabetes sind die Chancen, einen Myokardinfarkt zu überleben, in den letzten 15 Jahren deutlich gestiegen – nicht jedoch bei Betroffenen mit Typ 1.

15% bedauern gewählte Blasenkrebs-Therapie

29.05.2024 Urothelkarzinom Nachrichten

Ob Patienten und Patientinnen mit neu diagnostiziertem Blasenkrebs ein Jahr später Bedauern über die Therapieentscheidung empfinden, wird einer Studie aus England zufolge von der Radikalität und dem Erfolg des Eingriffs beeinflusst.

Costims – das nächste heiße Ding in der Krebstherapie?

28.05.2024 Onkologische Immuntherapie Nachrichten

„Kalte“ Tumoren werden heiß – CD28-kostimulatorische Antikörper sollen dies ermöglichen. Am besten könnten diese in Kombination mit BiTEs und Checkpointhemmern wirken. Erste klinische Studien laufen bereits.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.